PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Acupuncture for idiopathic pulmonary fibrosis: Protocol for a systematic review.

Abstract Patients with idiopathic pulmonary fibrosis (IPF) often suffer from progressive worsening of dyspnea and lung function. Although 2 drugs are now available for IPF treatment, many gaps are still to be filled. Evidences suggest that there may be some beneficial effect of acupuncture on pulmonary diseases. This review aims to systematically determine the efficacy and safety of acupuncture for treating IPF.
PMID
Related Publications

Acupuncture for asthma: Protocol for a systematic review.

Acupuncture for patients with vascular dementia: a systematic review protocol.

Acupuncture for psoriasis: protocol for a systematic review.

Acupuncture for treating sciatica: a systematic review protocol.

Acupuncture for patients with chronic urticaria: a systematic review protocol.

Authors

Mayor MeshTerms

Acupuncture Therapy

Keywords
Journal Title medicine
Publication Year Start




PMID- 29384901
OWN - NLM
STAT- MEDLINE
DCOM- 20180209
LR  - 20180209
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Linking)
VI  - 96
IP  - 52
DP  - 2017 Dec
TI  - Acupuncture for idiopathic pulmonary fibrosis: Protocol for a systematic review.
PG  - e9114
LID - 10.1097/MD.0000000000009114 [doi]
AB  - BACKGROUND: Patients with idiopathic pulmonary fibrosis (IPF) often suffer from
      progressive worsening of dyspnea and lung function. Although 2 drugs are now
      available for IPF treatment, many gaps are still to be filled. Evidences suggest 
      that there may be some beneficial effect of acupuncture on pulmonary diseases.
      This review aims to systematically determine the efficacy and safety of
      acupuncture for treating IPF. METHODS: The following 8 databases will be searched
      from their inception to March 20, 2017: PubMed, Embase, Cochrane Central Register
      of Controlled Trials, Web of Science, Chinese Biomedical Literature Database,
      China National Knowledge Infrastructure, Chongqing VIP, and Wanfang Data.
      Randomized controlled trials (RCTs) of acupuncture for IPF without restriction of
      publication status will be included. Two review authors will independently
      undertake study selection, extraction of data, and assessment of study quality.
      Meta-analysis will be conducted after screening of studies if possible.
      Dichotomous data will be analyzed using odds ratio (OR), and continuous data mean
      difference (MD). Statistical analysis will be conducted using Review Manager
      (RevMan) software. RESULTS: This systematic review will provide a detailed
      summary of the current evidences related to the efficacy and safety of
      acupuncture in improving breathlessness, exercise limitation, health status
      impairment of patients with IPF. CONCLUSION: This evidence may be useful to
      clinicians, patients, and health policy-makers with regard to the use of
      acupuncture in IPF treatment. ETHICS AND DISSEMINATION: This systematic review
      will provide up-to-date information on acupuncture for IPF. This review does not 
      require ethical approval and will be disseminated electronically through a
      peer-reviewed publication or conference presentations. TRIAL REGISTRATION NUMBER:
      PROSPERO 2017:CRD42017059848.
CI  - Copyright (c) 2017 The Authors. Published by Wolters Kluwer Health, Inc. All
      rights reserved.
FAU - Xie, Yang
AU  - Xie Y
AD  - Department of Respiratory Diseases, the First Affiliated Hospital of Henan
      University of Chinese Medicine.
AD  - Henan Key Laboratory of Chinese Medicine for Respiratory Disease.
AD  - Collaborative Innovation Center for Respiratory Disease Diagnosis and Treatment
      and Chinese Medicine Development of Henan Province, Henan University of Chinese
      Medicine, Zhengzhou, Henan Province, China.
FAU - Wang, Jia-Jia
AU  - Wang JJ
AD  - Henan Key Laboratory of Chinese Medicine for Respiratory Disease.
AD  - Collaborative Innovation Center for Respiratory Disease Diagnosis and Treatment
      and Chinese Medicine Development of Henan Province, Henan University of Chinese
      Medicine, Zhengzhou, Henan Province, China.
FAU - Li, Gao-Yang
AU  - Li GY
AD  - Henan Key Laboratory of Chinese Medicine for Respiratory Disease.
AD  - Collaborative Innovation Center for Respiratory Disease Diagnosis and Treatment
      and Chinese Medicine Development of Henan Province, Henan University of Chinese
      Medicine, Zhengzhou, Henan Province, China.
FAU - Li, Xuan-Lin
AU  - Li XL
AD  - Henan Key Laboratory of Chinese Medicine for Respiratory Disease.
AD  - Collaborative Innovation Center for Respiratory Disease Diagnosis and Treatment
      and Chinese Medicine Development of Henan Province, Henan University of Chinese
      Medicine, Zhengzhou, Henan Province, China.
FAU - Li, Jian-Sheng
AU  - Li JS
AD  - Henan Key Laboratory of Chinese Medicine for Respiratory Disease.
AD  - Collaborative Innovation Center for Respiratory Disease Diagnosis and Treatment
      and Chinese Medicine Development of Henan Province, Henan University of Chinese
      Medicine, Zhengzhou, Henan Province, China.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
SB  - AIM
SB  - IM
MH  - *Acupuncture Therapy
MH  - Humans
MH  - Idiopathic Pulmonary Fibrosis/complications/*therapy
MH  - Treatment Outcome
EDAT- 2018/02/01 06:00
MHDA- 2018/02/10 06:00
CRDT- 2018/02/01 06:00
PHST- 2018/02/01 06:00 [entrez]
PHST- 2018/02/01 06:00 [pubmed]
PHST- 2018/02/10 06:00 [medline]
AID - 10.1097/MD.0000000000009114 [doi]
AID - 00005792-201712290-00009 [pii]
PST - ppublish
SO  - Medicine (Baltimore). 2017 Dec;96(52):e9114. doi: 10.1097/MD.0000000000009114.